Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Okugawa

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Internal Medicine (Tokyo, Japan)|September 1, 1992
Wegener's granulomatosis in a patient with a rheumatoid arthritisH Ohashi, M Itoh, N Ogawa, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2000
Development of a cancer vaccine: peptides, proteins, and DNAH Shiku, L Wang, Y Ikuta, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1995
[Usefulness of palliative care for the patients with recurrent gastric cancer by home-IVH]M Sairenji, T Okamoto, H Motohashi, et al.
International Journal of Cancer|August 5, 2000
A HER2/NEU-derived peptide, a K(d)-restricted murine tumor rejection antigen, induces HER2-specific HLA-A2402-restricted CD8(+) cytotoxic T lymphocytesY Ikuta, T Okugawa, R Furugen, et al.
European Journal of Immunology|November 28, 2000
A novel human HER2-derived peptide homologous to the mouse K(d)-restricted tumor rejection antigen can induce HLA-A24-restricted cytotoxic T lymphocytes in ovarian cancer patients and healthy individualsT Okugawa, Y Ikuta, Y Takahashi, et al.
Alimentary Pharmacology & Therapeutics|November 17, 2011
Generation of dyspeptic symptoms by direct acid and water infusion into the stomachs of functional dyspepsia patients and healthy subjectsT Oshima, T Okugawa, T Tomita, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 13, 2000
Changes of hemostatic molecular markers after gynecological surgeryK Noda, H Wada, N Yamada, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Internal Medicine (Tokyo, Japan)|September 1, 1992
Wegener's granulomatosis in a patient with a rheumatoid arthritisH Ohashi, M Itoh, N Ogawa, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2000
Development of a cancer vaccine: peptides, proteins, and DNAH Shiku, L Wang, Y Ikuta, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1995
[Usefulness of palliative care for the patients with recurrent gastric cancer by home-IVH]M Sairenji, T Okamoto, H Motohashi, et al.
International Journal of Cancer|August 5, 2000
A HER2/NEU-derived peptide, a K(d)-restricted murine tumor rejection antigen, induces HER2-specific HLA-A2402-restricted CD8(+) cytotoxic T lymphocytesY Ikuta, T Okugawa, R Furugen, et al.
European Journal of Immunology|November 28, 2000
A novel human HER2-derived peptide homologous to the mouse K(d)-restricted tumor rejection antigen can induce HLA-A24-restricted cytotoxic T lymphocytes in ovarian cancer patients and healthy individualsT Okugawa, Y Ikuta, Y Takahashi, et al.
Alimentary Pharmacology & Therapeutics|November 17, 2011
Generation of dyspeptic symptoms by direct acid and water infusion into the stomachs of functional dyspepsia patients and healthy subjectsT Oshima, T Okugawa, T Tomita, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 13, 2000
Changes of hemostatic molecular markers after gynecological surgeryK Noda, H Wada, N Yamada, et al.
Pageof 3